By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton
The 2018 tax reform bill already is having tremendous impacts on business. In the life sciences industry, it is causing companies to rethink everything from asset repatriation to executive compensation. The changes generally are viewed favorably, although companies must rethink their strategies and business models, starting now, to ensure they gain maximum advantage.